Molecular convergence of neurodevelopmental disorders.
basic_science · Level V
Where this comes from
- Record sourced from PubMed, PMID 25307298.
- Also identified by DOI 10.1016/j.ajhg.2014.09.013 and PMC identifier 4225591.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Neurodevelopmental disorders (NDDs) are caused by mutations in diverse genes involved in different cellular functions, although there can be crosstalk, or convergence, between molecular pathways affected by different NDDs. To assess molecular convergence, we generated human neural progenitor cell models of 9q34 deletion syndrome, caused by haploinsufficiency of EHMT1, and 18q21 deletion syndrome, caused by haploinsufficiency of TCF4. Using next-generation RNA sequencing, methylation sequencing, chromatin immunoprecipitation sequencing, and whole-genome miRNA analysis, we identified several levels of convergence. We found mRNA and miRNA expression patterns that were more characteristic of differentiating cells than of proliferating cells, and we identified CpG clusters that had similar methylation states in both models of reduced gene dosage. There was significant overlap of gene targets of TCF4 and EHMT1, whereby 8.3% of TCF4 gene targets and 4.2% of EHMT1 gene targets were identical. These data suggest that 18q21 and 9q34 deletion syndromes show significant molecular convergence but distinct expression and methylation profiles. Common intersection points might highlight the most salient features of disease and provide avenues for similar treatments for NDDs caused by different genetic mutations.
Medical subject headings
- Basic Helix-Loop-Helix Leucine Zipper Transcription Factors
- Chromosome Disorders
- Craniofacial Abnormalities
- Evolution, Molecular
- Haploinsufficiency
- Heart Defects, Congenital
- Histone-Lysine N-Methyltransferase
- Intellectual Disability
- Neural Stem Cells
- Transcription Factors